272 related articles for article (PubMed ID: 25336498)
1. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
2. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
Satoh M; Maruhashi T; Yoshida Y; Shibata H
Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Comparative Study on Cardiac Alterations After Surgery and Drug Treatment of Primary Aldosteronism.
Chen YL; Xu TY; Xu JZ; Zhu LM; Li Y; Wang JG
Front Endocrinol (Lausanne); 2021; 12():770711. PubMed ID: 34867814
[TBL] [Abstract][Full Text] [Related]
8. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.
Sukor N; Gordon RD; Ku YK; Jones M; Stowasser M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2437-45. PubMed ID: 19401369
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
Cuspidi C; Tadic M; Sala C; Quarti-Trevano F; Gherbesi E; Mancia G; Grassi G
J Hypertens; 2021 Apr; 39(4):775-783. PubMed ID: 33044383
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C
Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803
[TBL] [Abstract][Full Text] [Related]
11. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.
Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA
Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883
[TBL] [Abstract][Full Text] [Related]
13. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
15. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
16. The Relation Between the Degree of Left Ventricular Mass Regression and Serum Potassium Level Change in Patients With Primary Aldosteronism After Adrenalectomy.
Liao CW; Chen A; Lin YT; Chang YY; Wang SM; Wu VC; Hung CS; Wu KD; Chueh SC; Lin YH;
J Investig Med; 2015 Aug; 63(6):816-20. PubMed ID: 26083251
[TBL] [Abstract][Full Text] [Related]
17. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
18. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
19. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A; Ragnarsson O; Johannsson G; Wängberg B
Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]